Drug Molnupiravir effective against Omicron, could reduce deaths: Study 

A new study revealed that a five-day course of antiviral drug, Molnupiravir, could be effective against highly contagious Omicron and other variants of concern (VOCs).

published on : 16th February 2022

105 nations to get cheaper Merck Covid pill; molnupiravir not added to India's treatment protocol due to safety concerns

However, due to safety concerns, India has not added Merck's pill to its national treatment protocol for the disease.

published on : 20th January 2022

COVID: Maharashtra government says Molnupiravir must be used with caution

He said this drug has received emergency use authorization (from the Drug Controller General of India) and based on the opinion of some experts it has also been included in treatment protocol.

published on : 18th January 2022

ICMR experts reject inclusion of Molnupiravir in Covid treatment guidelines for fourth time citing safety concerns

India's drug regulator on December 28 had approved the anti-Covid pill for restricted use in emergency situations.

published on : 13th January 2022

Molnupiravir not to be included in COVID-19 clinical management protocol as of now

The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at the decision in a meeting held on Monday.

published on : 12th January 2022

Self-medication with Molnupiravir can be dangerous: Experts

Dr Ravindra Mehta, Pulmonologist with Apollo Group of Hospitals, has warned people against using the drug unless prescribed by a medical practitioner.

published on : 11th January 2022

Mild COVID cases can be managed at home, Molnupiravir no magic drug, says AIIMS doctor

Molnupiravir works by inducing mutation in the virus by substituting one of the components that is also present in human genetic material.

published on : 10th January 2022

Lupin launches Molnulup for COVID-19 treatment

Molnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 patients who have a high risk of progression of the disease.

published on : 7th January 2022

Covid antiviral drug Molnupiravir has major safety concerns: ICMR chief

During a press briefing, he said the World Health Organisation and the UK have not included it for treatment.

published on : 6th January 2022

Aurobindo Pharma launches COVID-19 drug Molnupiravir in India

Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, a press release from the city-based drug maker said.

published on : 6th January 2022

Doctors have different views on new drug

Molnupiravir, the antiviral drug for COVID-19, has hit the market within a week of receiving emergency use authorisation.

published on : 5th January 2022

Anti-COVID pill to be rolled out shortly; eight vaccines, four treatments now in India's arsenal

Strides, Dr Reddy's, Sun Pharma, Cipla, Hetero, Torrent and Optimus said they have received approvals from the DCGI to manufacture and market their versions of Molnupiravir.

published on : 29th December 2021

Two more vaccines and a pill added to India's inventory to combat Covid 

DCGI on Tuesday gave emergency use authorisation (EUA) to Covid vaccines Covovax and Corbevax, apart from Covid drug molnupiravir.

published on : 29th December 2021

Optimus Pharma to launch COVID-19 drug Molnupiravir shortly

Optimus Pharma has revealed highly promising results of the drug in its ability to reduce viral load and bring out significant symptomatic improvement in patient's health.

published on : 28th December 2021

Boost for India's COVID fight as country approves vaccines Corbevax, Covovax and Molnupiravir pill

With this approval, the number of Covid vaccines which have received emergency use authorisation in the country has increased to eight.

published on : 28th December 2021
1 2 >